Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
DOI
PMC
 |
|
Open Access Green as soon as Postprint is submitted to ZB.
Proton beam therapy and carbon ion radiotherapy for hepatocellular carcinoma.
Semin. Radiat. Oncol. 28, 309-320 (2018)
Charged particle therapy with proton beam therapy (PBT) and carbon ion radiotherapy (CIRT) has emerged as a promising radiation modality to minimize radiation hepatotoxicity while maintaining high rates of tumor local control. Both PBT and CIRT deposit the majority of their dose at the Bragg peak with little to no exit dose, resulting in superior sparing of normal liver tissue. CIRT has an additional biological advantage of increased relative biological effectiveness, which may allow for increased hypofractionation regimens. Retrospective and prospective studies have demonstrated encouragingly high rates of local control and overall survival and low rates of hepatotoxicity with PBT and CIRT. Ongoing randomized trials will evaluate the value of PBT over photons and other standard liver-directed therapies and future randomized trials are needed to assess the value of CIRT over PBT.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Review
Keywords
Stereotactic Body Radiotherapy; Effectiveness Rbe Values; Radiation-therapy; Phase-ii; Transarterial Chemoembolization; Liver Toxicity; Porta-hepatis; Irradiation; Cirrhosis; Model
ISSN (print) / ISBN
1053-4296
e-ISSN
1532-9461
Journal
Seminars in Radiation Oncology
Quellenangaben
Volume: 28,
Issue: 4,
Pages: 309-320
Publisher
Elsevier
Publishing Place
1600 John F Kennedy Boulevard, Ste 1800, Philadelphia, Pa 19103-2899 Usa
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Radiation Medicine (IRM)